Abbott Laboratories (ABT) vs Boston Scientific Corporation (BSX)
- Abbott Laboratories ABT 110.37 −2.84%
- Boston Scientific Corporation BSX 43.00 −3.67%
Abbott Laboratories and Boston Scientific Corporation are both Medical Devices companies. Abbott Laboratories is the larger, with a market value of $196.6B against $64.7B — 3.0× the size. Boston Scientific Corporation trades at the lower P/E: 18.7× against 42.3×. Abbott Laboratories grew revenue faster over the last twelve months: 10.0% against 8.87%. Boston Scientific Corporation has the higher net margin (16.6% vs 9.75%) and the higher return on invested capital (6.60% vs 0.00%). Across the 22 metrics below, Boston Scientific Corporation leads on 18 and Abbott Laboratories on 4.
Valuation
Profitability
| Metric | ABT | BSX | Medical Devices median |
|---|---|---|---|
| Gross margin | 56.94% | 69.14% | 57.76% |
| Operating margin | 13.78% | 18.65% | (15.07%) |
| Net margin | 9.75% | 16.62% | (14.45%) |
| Free cash flow margin | 0.00% | 15.81% | (3.88%) |
| Return on equity | 0.00% | 14.15% | (10.35%) |
| Return on assets | 0.00% | 7.94% | (17.26%) |
| Return on invested capital | 0.00% | 6.60% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack